Crystalline cannabidivarin

US10053407B2 · kind B2 · utility

Assignee

• S&B Pharma, Inc. · US

Inventors

• Daniel A. Dickman · Grayslake, US
• Emerich Eisenreich · Claremont, US
• Daniel Levin · Tustin, US
• Mackenzie Marrs · Pasadena, US

Key dates

• Filing date: May 31, 2017
• Grant date: Aug 21, 2018
• Expiry date: May 31, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2601/16
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Solid cannabidivarin, crystalline cannabidivarin, (R,R)-(−)-crystalline cannabidivarin, (S,S)-(+)-crystalline cannabidivarin and substantially pure forms thereof are disclosed herein. Further disclosed are methods of making such cannabidivarin, compositions and formulations comprising such cannabidivarin, and methods of treating disease with such cannabidivarin.